PuraMed BioScience and Honoring Our Troops Partner Together to Sponsor a PTSD Event
SCHOFIELD, Wis., June 11, 2014 /PRNewswire/ -- PuraMed BioScience®, Inc., (OTCBB: PMBS), a researcher, developer, and marketer of over-the-counter (OTC) medicinal and healthcare products, announced today that in conjunction with Migraine Awareness month, the company sponsored the San Diego Operation Engage America event with Honoring Our Troops on Saturday, June 7, 2014. PuraMed provided samples of LipiGesic® M along with educational information for veterans, which was distributed at the Honoring Our Troops booth.
"We were honored to participate in this inaugural event," said Russell Mitchell, Chairman and CEO of PuraMed BioScience. "There are so many veterans who suffer from both post traumatic-stress disorder (PTSD) and migraine, but they are unable to treat both conditions because of drug interactions. Providing our veterans with a product that will make a real difference in their lives fulfills the mission and purpose on which our company was founded."
Operation Engage America (OEA) is a grassroots organization started by two families who were looking for answers when their sons, who served our country in Iraq and Afghanistan, lost their inner battles with PTSD and traumatic brain injuries (TBI).
Operation Engage America has partnered with the American Legion, VFW, IAVA, Paralyzed Veterans of America and the VA to bring awareness, support and help to those who suffer PTSD and TBI.
According to the organization's website, www.operation-engage-america.org, PTSD is not limited to service men and women, but can affect "…first responders, victims of domestic, child and sexual abuse, even some of those who've experienced natural disasters and automobile accidents…" In recognition of June being PTSD Awareness month, Operation Engage America, held the first of what it hopes are many events across the country to bring awareness, support, help, and healing to veterans and their families.
"We appreciate PuraMed BioScience's support at this event," said Sarah Tipton, Military Veteran Advocate, Honoring Our Troops. "LipiGesic M has been requested in care packages we send overseas, but we are finding the need for this type of medication is just as great right here at home. PuraMed supplied us with product and information that was well received by our veterans and captured the interest of the medical community."
"The chance to partner with Honoring Our Troops during this event helped us get an effective product into the hands of the people who need it the most," said Mitchell. "Though the event was targeted toward veterans, it had an exceptionally large physician turnout. Interest from the doctors was very high. We also experienced a sample rate of over 50 percent. We are very excited about the results and looking forward to participating in the next event this summer."
About Honoring Our Troops
The mission and purpose of the Honoring Our Troops organization is to meet the needs of veterans by building community awareness and by direct, educational, and legal support to empower and improve the lives of our veterans and their families. For more information, visit www.hrtroops.org.
About PuraMed BioScience, Inc.
PuraMed BioScience engages in the research, development, and marketing of non-prescription medicinal and healthcare products. In addition to LipiGesic M, PuraMed BioScience plans to launch additional cannabinoid-enhanced anti-inflammatory and anxiolytic products as it moves forward in the development of its CBD product line.
This news release contains forward-looking statements regarding PuraMed BioScience, Inc., and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different from those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.
SOURCE PuraMed BioScience, Inc.